Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $19.6 Million - $22.8 Million
394,500 Added 52.22%
1,150,000 $58.6 Million
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $2.9 Million - $3.6 Million
53,900 Added 7.68%
755,500 $40.7 Million
Q2 2022

Aug 15, 2022

SELL
$63.83 - $80.0 $3.13 Million - $3.93 Million
-49,100 Reduced 6.54%
701,600 $45.1 Million
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $1.3 Million - $1.51 Million
16,897 Added 2.3%
750,700 $58.2 Million
Q4 2021

Feb 14, 2022

BUY
$74.57 - $87.19 $21.2 Million - $24.7 Million
283,803 Added 63.07%
733,803 $63 Million
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $33.2 Million - $37.6 Million
450,000 New
450,000 $36.2 Million
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $11.3 Million - $12.3 Million
-140,000 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$76.38 - $86.03 $12.3 Million - $13.9 Million
-161,000 Reduced 53.49%
140,000 $11.8 Million
Q4 2020

Feb 16, 2021

SELL
$75.39 - $82.36 $25.9 Million - $28.3 Million
-344,000 Reduced 53.33%
301,000 $24.2 Million
Q1 2020

May 15, 2020

BUY
$71.57 - $93.3 $8.59 Million - $11.2 Million
120,000 Added 22.86%
645,000 $52.4 Million
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $10.7 Million - $12.4 Million
140,000 Added 36.36%
525,000 $43.9 Million
Q3 2019

Nov 14, 2019

BUY
$81.4 - $89.78 $6.86 Million - $7.57 Million
84,300 Added 28.03%
385,000 $33.7 Million
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $227,365 - $287,860
3,700 Added 1.25%
300,700 $19.8 Million
Q1 2018

May 15, 2018

BUY
$62.56 - $72.26 $4.19 Million - $4.84 Million
67,000 Added 29.13%
297,000 $19.3 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $13.7 Million - $14.9 Million
230,000
230,000 $14.4 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.